Inhibition of tristetraprolin deadenylation by poly(A) binding protein

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 295, Issue 3, 2008, Pages

  Rowlett, Robert M ^a   Chrestensen, Carol A ^a   Schroeder, Melanie J ^b   Harp, Mary G ^a   Pelo, Jared W ^a   Shabanowitz, Jeffery ^b   DeRose, Robert ^c   Hunt, Donald F ^a,b   Sturgill, Thomas W ^a   Worthington, Mark T ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Immunology; RNA; Tumor necrosis factor

Indexed keywords

CHEMOKINE RECEPTOR CCR4; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NEOMYCIN; POLYADENYLATED RNA; POLYADENYLIC ACID BINDING PROTEIN; SPLEEN EXONUCLEASE; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR; ENZYME INHIBITOR; EXORIBONUCLEASE; POLY(A)-SPECIFIC RIBONUCLEASE; POLYADENYLATE SPECIFIC RIBONUCLEASE; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; TUMOR NECROSIS FACTOR ALPHA; ZFP36 PROTEIN, MOUSE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYTOKINE RELEASE; DEADENYLATION; ENZYME INHIBITION; ENZYME STABILITY; ENZYME SUBSTRATE; ENZYME SYNTHESIS; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MACROPHAGE; MASS SPECTROMETRY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; 3' UNTRANSLATED REGION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; RNA STABILITY; TIME;

3' UNTRANSLATED REGIONS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; ENZYME INHIBITORS; EXORIBONUCLEASES; GENE SILENCING; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOMYCIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; POLY(A)-BINDING PROTEIN I; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; RNA STABILITY; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 53449087497     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00508.2007     Document Type: Article

References (57)

1. Afonina E, Stauber R, Pavlakis GN. The human poly(A)-binding protein 1 shuttles between the nucleus and the cytoplasm. J Biol Chem 273: 13015-13021, 1998.
2. Amann BT, Worthington MT, Berg JM. A Cys3His zinc-binding domain from Nup475/tristetraprolin: a novel fold with a disklike structure. Biochemistry 42: 217-221, 2003.
3. Anderson P, Kedersha N. Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation. Cell Stress Chaperones 7: 213-221, 2002.
4. Beutler B, Bazzoni F. TNF, apoptosis and autoimmunity-a common thread. Blood Cells Mol Dis 24: 216-230, 1998.
5. Bollig F, Winzen R, Gaestel M, Kostka S, Resch K, Holtmann H. Affinity purification of ARE-binding proteins identifies poly(A)-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization. Biochem Biophys Res Commun 301: 665-670, 2003.
6. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, Saklatvala J, Clark AR. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol 26: 2408-2418, 2006.
7. Carballo E, Gilkeson GS, Blackshear PJ. Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction. J Clin Invest 100: 986-995, 1997.
8. Carballo E, Lai WS, Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95: 1891-1899, 2000.
9. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005, 1998.
10. Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT, Sturgill TW. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 279: 10176-10184, 2004.
11. Coller JM, Gray NK, Wickens MP. mRNA stabilization by poly(A) binding protein is independent of poly(A) and requires translation. Genes Dev 12: 3226-3235, 1998.
12. Crawford EK, Ensor JE, Kalvakolanu I, Hasday JD. The role of 3′ poly(A) tail metabolism in tumor necrosis factor-alpha regulation. J Biol Chem 272: 21120-21127, 1997.
13. Dean JL, Sarsfield SJ, Tsounakou E, Saklatvala J. p38 Mitogen-activated protein kinase stabilizes mRNAs that contain cyclooxygenase-2 and tumor necrosis factor AU-rich elements by inhibiting deadenylation. J Biol Chem 278: 39470-39476, 2003.
14. Deleault KM, Skinner SJ, Brooks SA. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol Immunol 45: 13-24, 2008.
15. DuBois RN, Bishop PR, Graves-Deal R, Coffey RJ. Transforming growth factor alpha regulation of two zinc finger-containing immediate early response genes in intestine. Cell Growth Differ 6: 523-529, 1995.
16. DuBois RN, McLane MW, Ryder K, Lau LF, Nathans D. A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. J Biol Chem 265: 19185-19191, 1990.
17. Ehrenfried JA, Townsend CM Jr, Thompson JC, Evers BM. Increases in nup475 and c-jun are early molecular events that precede the adaptive hyperplastic response after small bowel resection. Ann Surg 222: 51-56, 1995.
18. Franks TM, Lykke-Andersen J. TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements. Genes Dev 21: 719-735, 2007.
19. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 171: 465-475, 1990.
20. Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol 11: 257-264, 2004.
21. Johnson BA, Geha M, Blackwell TK. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene 19: 1657-1664, 2000.
22. Kahvejian A, Svitkin YV, Sukarieh R, M'Boutchou MN, Sonenberg N. Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms. Genes Dev 19: 104-113, 2005.
23. Kedersha N, Cho MR, Li W, Yacono PW, Chen S, Gilks N, Golan DE, Anderson P. Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J Cell Biol 151: 1257-1268, 2000.
24. Khaleghpour K, Svitkin YV, Craig AW, DeMaria CT, Deo RC, Burley SK, Sonenberg N. Translational repression by a novel partner of human poly(A) binding protein, Paip2. Mol Cell 7: 205-216, 2001.
25. Khanna R, Kiledjian M. Poly(A)-binding-protein-mediated regulation of hDcp2 decapping in vitro. EMBO J 23: 1968-1976, 2004.
26. Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, Gaestel M. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1: 94-97, 1999.
27. Kusov YY, Shatirishvili G, Dzagurov G, Gauss-Muller V. A new G-tailing method for the determination of the poly(A) tail length applied to hepatitis A virus RNA. Nucleic Acids Res 29: E57, 2001.
28. Kuyumcu-Martinez NM, Van Eden ME, Younan P, Lloyd RE. Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff. Mol Cell Biol 24: 1779-1790, 2004.
29. Lagnado CA, Brown CY, Goodall GJ. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol Cell Biol 14: 7984-7995, 1994.
30. Lai WS, Kennington EA, Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU- rich element-containing mRNAs. J Biol Chem 277: 9606-9613, 2002.
31. Lai WS, Kennington EA, Blackshear PJ. Tristetraprolin and its family members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease. Mol Cell Biol 23: 3798-3812, 2003.
32. Lu JY, Schneider RJ. Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay. J Biol Chem 279: 12974-12979, 2004.
33. Lykke-Andersen J, Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev 19: 351-361, 2005.
34. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21: 6461-6469, 2001.
35. Michel YM, Poncet D, Piron M, Kean KM, Borman AM. Cap-Poly(A) synergy in mammalian cell-free extracts. Investigation of the requirements for poly(A)-mediated stimulation of translation initiation. J Biol Chem 275: 32268-32276, 2000.
36. Milone J, Wilusz J, Bellofatto V. Characterization of deadenylation in trypanosome extracts and its inhibition by poly(A)-binding protein Pab1p. RNA 10: 448-457, 2004.
37. Murata T, Morita N, Hikita K, Kiuchi K, Kiuchi K, Kaneda N. Recruitment of mRNA-destabilizing protein TIS11 to stress granules is mediated by its zinc finger domain. Exp Cell Res 303: 287-299, 2005.
38. Okochi K, Suzuki T, Inoue J, Matsuda S, Yamamoto T. Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control. Genes Cells 10: 151-163, 2005.
39. Penalva LO, Burdick MD, Lin SM, Sutterluety H, Keene JD. RNA-binding proteins to assess gene expression states of co-cultivated cells in response to tumor cells. Mol Cancer 3: 24, 2004.
40. Ren YG, Martinez J, Kirsebom LA, Virtanen A. Inhibition of Klenow DNA polymerase and poly(A)-specific ribonuclease by aminoglycosides. RNA 8: 1393-1400, 2002.
41. Rigby WF, Roy K, Collins J, Rigby S, Connolly JE, Bloch DB, Brooks SA. Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function. J Immunol 174: 7883-7893, 2005.
42. Rowlett RM, Chrestensen CA, Nyce M, Harp MG, Pelo JW, Cominelli F, Ernst PB, Pizarro TT, Sturgill TW, Worthington MT. MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages. Am J Physiol Gastrointest Liver Physiol 294: G452-G459, 2008.
43. Sachs AB, Davis RW, Kornberg RD. A single domain of yeast poly(A)-binding protein is necessary and sufficient for RNA binding and cell viability. Mol Cell Biol 7: 3268-3276, 1987.
44. Salles FJ, Darrow AL, O'Connell ML, Strickland S. Isolation of novel murine maternal mRNAs regulated by cytoplasmic polyadenylation. Genes Dev 6: 1202-1212, 1992.
45. Sladic RT, Lagnado CA, Bagley CJ, Goodall GJ. Human PABP binds AU-rich RNA via RNA-binding domains 3 and 4. Eur J Biochem 271: 450-457, 2004.
46. Stoecklin G, Ming XF, Looser R, Moroni C. Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol Cell Biol 20: 3753-3763, 2000.
47. Tallada VA, Daga RR, Palomeque C, Garzon A, Jimenez J. Genomewide search of Schizosaccharomyces pombe genes causing overexpression-mediated cell cycle defects. Yeast 19: 1139-1151, 2002.
48. Taylor GA, Thompson MJ, Lai WS, Blackshear PJ. Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J Biol Chem 270: 13341-13347, 1995.
49. Wakiyama M, Honkura N, Miura KI. Interference with interaction between eukaryotic translation initiation factor 4G and poly(A)-binding protein in Xenopus oocytes leads to inhibition of polyadenylated mRNA translation and oocyte maturation. J Biochem (Tokyo) 130: 737-740, 2001.
50. Wang Z, Day N, Trifillis P, Kiledjian M. An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol Cell Biol 19: 4552-4560, 1999.
51. Wormington M, Searfoss AM, Hurney CA. Overexpression of poly(A) binding protein prevents maturation-specific deadenylation and translational inactivation in Xenopus oocytes. EMBO J 15: 900-909, 1996.
52. Worthington MT, Amann BT, Nathans D, Berg JM. Metal binding properties and secondary structure of the zinc-binding domain of Nup475. Proc Natl Acad Sci USA 93: 13754-13759, 1996.
53. Worthington MT, Pelo JW, Sachedina MA, Applegate JL, Arseneau KO, Pizarro TT. RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein. J Biol Chem 277: 48558-48564, 2002.
54. Yang H, Duckett CS, Lindsten T. iPABP, an inducible poly(A)-binding protein detected in activated human T cells. Mol Cell Biol 15: 6770-6776, 1995.
55. Yonan CR, Duong PT, Chang FN. High-efficiency staining of proteins on different blot membranes. Anal Biochem 338: 159-161, 2005.
56. Zhu W, Brauchle MA, Di Padova F, Gram H, New L, Ono K, Downey JS, Han J. Gene suppression by tristetraprolin and release by the p38 pathway. Am J Physiol Lung Cell Mol Physiol 281: L499-L508, 2001.
57. Zubiaga AM, Belasco JG, Greenberg ME. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15: 2219-2230, 1995.